Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags

Area of Science:

• Immunology
• Microbiology
• Biotechnology

Background:

• Pathogens evolve immune evasion strategies, hindering host defense.
• Current treatments face challenges from resistant bacterial strains.
• Novel therapeutic approaches are needed to overcome pathogen immune evasion.

Purpose of the Study:

• To develop a novel chimeric agent for targeting and eliminating immune-evading pathogens.
• To create a tool that recruits the host's immune system against resistant bacteria.
• To demonstrate the efficacy of a peptide-protein conjugate in enhancing complement-mediated bacterial killing.

Main Methods:

• Conjugation of a peptide bacterial binder with the C3b complement system activating protein to create a chimeric agent.
• Assessment of the chimeric C3b tag's activity and binding affinity to complement protein C5.
• In vitro testing of the chimeric agent's efficacy against complement-resistant *E. coli*.

Main Results:

• The developed chimeric C3b tag retained its functional activity and demonstrated strong binding to C5.
• The chimeric agent successfully eradicated 90% of complement-resistant *E. coli* bacterial cells.
• The study showed enhanced complement sensitivity in pathogens treated with the chimeric agent.

Conclusions:

• A novel chimeric agent effectively targets and eliminates immune-evading bacteria by leveraging the complement system.
• This approach offers a promising new therapeutic strategy for combating antibiotic-resistant bacterial infections.
• The findings pave the way for developing selective and potent antimicrobial agents.